PatternsRadar
Sign in

INDGNIndegene Limited

NSE
Full chart
596.30INR-2.15 (-0.36%)Close · 6 Oct 2026
30 Jul 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹14,369 CrMarket cap
35.8P/E (TTM)
53.7%Delivery

Filings & corporate actions

10 results filed
CSV
Next results · Q2 FY27
Expected 28 Oct 2026 – 31 Oct 2026
Estimate: filed 28–31 days after quarter end, last 8 times
Dividend
₹2.25 per share · last 31 Jul 2026
2026
  • 31 JuldividendDividend · ₹2.25 per share+0.1%
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.1%NSE
  • 17 JulshareholdingShareholding · 30 Jun 20260.0%NSE
  • 29 AprresultsResults · Q4 FY26 · consolidated and standalone+0.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026-1.0%NSE
  • 29 JanresultsResults · Q3 FY26 · consolidated and standalone+2.8%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025+0.4%NSE

Reaction to results · all yearsrose on day 0 in 4 of 10 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2730 Jul 2026+0.1%+7.7%+12.5%5.7×
Q4 FY2629 Apr 2026+0.9%+7.0%+2.9%1.9×
Q3 FY2629 Jan 2026+2.8%+2.4%+6.6%3.1×
Q2 FY2630 Oct 2025-2.3%-6.1%-4.6%1.1×
Q1 FY2631 Jul 2025+6.3%+5.2%+0.6%13.9×
Q4 FY2528 Apr 2025-2.3%-3.1%+2.8%1.5×
Q3 FY2530 Jan 2025-0.2%+3.9%-14.4%0.9×
Q2 FY2528 Oct 2024-5.5%-4.0%-0.8%1.6×
Q1 FY251 Aug 2024-2.3%-3.4%-1.5%1.0×
Q4 FY2430 May 2024-2.3%+0.2%+5.4%—
Average-0.5%+1.0%+0.9%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+39.7%
Profit YoY-0.2%
Interest cost YoY+57.1%
Revenue QoQ+5.9%
Profit QoQ+45.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open595.00
Day range591.00 – 598.40
52-week range414.00 – 627.00
From 52w high-4.9%
RSI (14)54.3
ATR (14)18.36
Volume1.33L
Avg volume (20D)5.01L
Rel volume0.27×
Volatility (1Y)27.3%
Turnover₹7.9Cr
SMA 50 / 200573.80 / 516.69

Delivery percentage

Latest · 6 Oct 202653.7%
20-day avg51.1%
1-year avg57.1%
Percentile (own history)49th
Range7.1–86.3%
Sessions597

Over the last 20 sessions INDGN settled 51.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 57.1%, so recent sessions are running 6.1 points lower than usual. The latest session ranks higher than 49% of the 597 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Research Analytics & Technology

Performance returns

CSV
1D1W1M3M6M1Y
Price-0.36%-2.77%-0.64%+21.24%+26.17%+3.63%

Valuation

CSV
Market cap₹14,369 Cr
P/E (TTM)35.8
EPS (TTM)16.64
Shares outstanding24.05Cr
Listed13 May 2024

Ownership

CSV
Promoter0.00%
Promoter Δ QoQ0.00 pp
Public100.00%
FII9.91%
DII8.74%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)804.2942.11,003.41,063.1
YoY chg+17.1%+30.8%+32.8%+39.7%
Net profit (₹ Cr)102.1102.979.7116.2
YoY chg+11.3%-6.2%-32.2%-0.2%
Net margin12.7%10.9%7.9%10.9%
EPS4.234.263.304.81

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 0.00% · public 100.00%
10 May 2024: promoter 0.00%30 Jun 2024: promoter 0.00%30 Sept 2024: promoter 0.00%31 Dec 2024: promoter 0.00%31 Mar 2025: promoter 0.00%30 Jun 2025: promoter 0.00%30 Sept 2025: promoter 0.00%31 Dec 2025: promoter 0.00%31 Mar 2026: promoter 0.00%30 Jun 2026: promoter 0.00%
2024-052026-06
  • Promoter
  • Public and others
Promoter
0.00%
Public
100.00%
Promoter change
0.00 pp
Filed
17 Jul 2026
FII
9.91%
DII
8.74%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue from operations673.0676.5686.8720.4755.6760.8804.2942.11,003.41,063.1
Other income23.222.521.437.725.622.119.719.410.829.0
Total income696.2699.0708.2758.1781.2782.9823.9961.51,014.21,092.1
Total expenses565.1579.4584.1611.8631.9630.8690.8826.8888.8939.4
└ Finance costs12.311.74.03.23.13.73.84.67.26.4
└ Depreciation18.520.119.420.020.721.623.439.641.844.1
Profit before tax133.5119.6124.1146.3149.3152.1133.1134.7105.1152.7
Tax expense38.731.932.436.631.735.731.031.825.436.5
Net profit94.887.791.7109.7117.6116.4102.1102.979.7116.2
EPS4.273.793.844.594.914.864.264.293.324.84
Net margin14.09%12.96%13.35%15.23%15.56%15.30%12.70%10.92%7.94%10.93%
PBT margin19.84%17.68%18.07%20.31%19.76%19.99%16.55%14.30%10.47%14.36%
Tax rate28.99%26.67%26.11%25.02%21.23%23.47%23.29%23.61%24.17%23.90%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 30 Jul 2026.

INDGN at a glance

  • INDGN closed at ₹596.3 on 6 Oct 2026, -0.36% on the day, +3.6% over one year, 4.9% below its 52-week high of ₹627.
  • Delivery was 53.7% of traded quantity on 6 Oct 2026, the 49th percentile of its own 597 sessions with a reading (20-session average 51.1%, 1-year average 57.1%).
  • Market capitalisation is ₹14,369 crore at a trailing P/E of 35.8 (trailing EPS ₹16.64).
  • Q1 FY27 results (consolidated, filed 30 Jul 2026): revenue ₹1,063 crore (+39.7% year on year), net profit ₹116 crore (-0.2%); the price moved +0.1% on the first session after.
  • Promoters held 0.00% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 28 Oct 2026 and 31 Oct 2026, going by past filing dates — an estimate, not an announcement.